Oxford Drug Design (ODD) has won a UK-China antimicrobial resistance grant, in addition to also boosting its funding with investment from the Angel CoFund. Oxford Drug Design Limited has raised a combined £2.2m in funding from the Angel CoFund (ACF), o2h Ventures and other new investors. Whilst also gaining grant funding from the UK Department
Director of Manufacturing & NPIScientific ProfessionalsWiltshire, UK
- FULL TIME
Document Management SpecialistScientific ProfessionalsUK, South East
Aseptic Compounding TechnicianScientific ProfessionalsUK, Tyne and Wear
- FULL TIME
Business Insights and Intelligence ManagerScientific ProfessionalsUK, South East
Scientific and Engineering Recruitment
At Scientific Professionals we are committed to finding the best talent within the scientific marketplace. Our candidates play a key role in developing cutting-edge treatments, diagnostics and future therapies.
Our experience spans the full product life cycle - from innovation to manufacturing - and guarantees an in-depth understanding of both client and candidate requirements. Additionally we have expert knowledge of the Regulatory sector with first hand knowledge of GMP, ISO and FDA guidelines at all levels. Mirroring the dynamics of this marketplace our consultants work quickly and efficiently to identify and assess the right person, at the right time, in the right location.
Scientific Professionals have the capability and resource to cover key markets throughout Europe, and with our country specific consultant teams we have unrivaled access to Local Market Knowledge and Country Specific Networks, a structure which reduces lead times and guarantees a rapid and effective service.
Our teams are comprised of Senior Consultants who have acquired degree level qualifications in Scientific or Engineering disciplines and have a wealth of experience in recruiting for roles at all levels within the Scientific and Engineering sectors.
A new study has suggested that whilst treating peanut allergy with regular exposure to small amounts of the food is effective it is only if a patient stays on the therapy. The King’s College London scientists conducting the looked at the underlying behaviour of patients’ cells and found it did not change. They stated it
According to scientist a rare and unfortunate sequence of events have allowed a deadly type of malaria in gorillas to “jump” species and attack humans. Hundreds of thousands of people die from malaria every year and Plasmodium falciparum, the type the researchers studied, is responsible in most cases. Experts have found that although African great apes